Published in Br J Haematol on April 01, 1999
IgH gene rearrangements as plasma biomarkers in Non- Hodgkin's lymphoma patients. Oncotarget (2011) 2.34
Molecular diagnostic approach to non-Hodgkin's lymphoma. J Mol Diagn (2000) 1.19
Recent advances in management of acute leukaemia. Arch Dis Child (2000) 0.89
Time point-dependent concordance of flow cytometry and real-time quantitative polymerase chain reaction for minimal residual disease detection in childhood acute lymphoblastic leukemia. Haematologica (2012) 0.89
Chronic myeloid leukemia: a minimalistic view of post-therapeutic monitoring. J Mol Diagn (2002) 0.76
The e19a2 bcr/abl breakpoint in acute lymphoblastic leukaemia. Br J Haematol (2000) 0.75
Detection of minimal residual disease by flow cytometry for patients with multiple myeloma submitted to autologous hematopoietic stem cell transplantation. ISRN Hematol (2013) 0.75
A study of proximal and distal intestinal structure and absorptive function in idiopathic steatorrhoea. Q J Med (1967) 4.68
Method of assay of red cell folate activity and the value of the assay as a test for folate deficiency. J Clin Pathol (1966) 4.44
Tissue antibodies in dermatitis herpetiformis and adult coeliac disease. Lancet (1971) 3.50
Small-intestinal structure and function and haematological changes in dermatitis herpetiformis. Lancet (1967) 3.11
Circulating immune complexes in dermatitis herpetiformis. Lancet (1973) 2.78
Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J (1995) 2.73
Anti-reticulin antibodies in childhood coeliac disease. Lancet (1971) 2.54
Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Leukemia (2005) 2.35
Efficacy and possible adverse effects of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in thalassemia major. Blood (1992) 2.29
Folic acid fortification and cancer risk. Lancet (2007) 2.17
Antireticulin antibody: incidence and diagnostic significance. Gut (1973) 2.15
Lymphocytic infiltration of epithelium in diagnosis of gluten-sensitive enteropathy. Br Med J (1972) 2.11
Effect of gluten-free diet on dermatological, intestinal, and haematological manifestations of dermatitis herpetiformis. Lancet (1968) 2.09
Clearance of skin lesions in dermatitis herpetiformis after gluten withdrawal. Lancet (1973) 2.01
Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. Lancet (1982) 2.01
Parenteral acyclovir therapy for herpesvirus infections in man. Lancet (1979) 1.99
A laboratory comparison of T cell depletion by CD34+ cell immunoaffinity selection and in vitro Campath-1M treatment: clinical implications for bone marrow transplantation and donor leukocyte therapy. Bone Marrow Transplant (1997) 1.96
The human thymic microenvironment: an immunohistologic study. J Immunol (1980) 1.94
Combined therapy with deferiprone and desferrioxamine. Br J Haematol (1998) 1.91
Agranulocytosis and thrombocytopenia in patient with Blackfan-Diamond anaemia during oral chelator trial. Lancet (1989) 1.91
Folate deficiency and neurological disease. Lancet (1965) 1.85
Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol (1996) 1.82
Waiting times and patient satisfaction in the accident and emergency department. Arch Emerg Med (1992) 1.82
Subcutaneous infusion and intramuscular injection of desferrioxamine in patients with transfusional iron overload. Lancet (1976) 1.81
Hypoparathyroidism and hypocalcaemia during treatment for acute leukaemia. Br Med J (Clin Res Ed) (1982) 1.72
Improvement in iron status and liver function in patients with transfusional iron overload with long-term subcutaneous desferrioxamine. Lancet (1979) 1.70
Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma. Leukemia (2006) 1.69
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia (2003) 1.64
Serum ferritin assay and iron status in chronic renal failure and haemodialysis. Br Med J (1975) 1.61
Gluten-free diet and reintroduction of gluten in dermatitis herpetiformis. Arch Dermatol (1969) 1.60
Deletion analysis of chromosome 13q14.3 and characterisation of an alternative splice form of LEU1 in B cell chronic lymphocytic leukemia. Leukemia (2002) 1.60
Bone-marrow aspiration and trephine biopsy (1). Br Med J (1980) 1.58
Mechanism of folate deficiency in patients receiving phenytoin. Lancet (1968) 1.58
Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia. Lancet (1982) 1.55
The hematologic complications following partial gastrectomy. A study of 292 patients. Am J Med (1967) 1.55
The small intestine in dermatitis herpetiformis. J Clin Pathol (1974) 1.54
ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia. Leukemia (2002) 1.54
Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol (2000) 1.54
Immunoglobulins in the skin in dermatitis herpetiformis and coeliac disease. Lancet (1972) 1.53
Unusual megaloblastic anaemia wiht multinucleate erythroblasts: two cases with septicaemia and acute renal failure. J Clin Pathol (1975) 1.53
Subpopulations of normal and leukemic human thymocytes: an analysis with the use of monoclonal antibodies. J Natl Cancer Inst (1980) 1.50
Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunodeficient child. J Virol (1991) 1.47
Multiple immune complexes and hypocomplementaemia in dermatitis herpetiformis and coeliac disease. Lancet (1976) 1.45
Increased numbers of cells with suppressor T cell phenotype in the peripheral blood of patients with infectious mononucleosis. Clin Exp Immunol (1981) 1.45
Iron chelation therapy: the need for orally active drugs. J Lab Clin Med (1998) 1.42
Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue. J Immunol (1985) 1.41
Serum immunoreactive trypsin in beta-thalassaemia major. J Clin Pathol (1981) 1.41
Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980-2001. Leukemia (2009) 1.40
Baller Gerold syndrome and Fanconi anaemia. Am J Med Genet (1998) 1.39
Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients. Clin Infect Dis (1992) 1.39
Crystal structure of an ephrin ectodomain. Dev Cell (2001) 1.37
Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial. Br Med J (Clin Res Ed) (1983) 1.37
Absorption of crystalline folic acid in man. Lancet (1968) 1.35
Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma. Leukemia (2005) 1.35
Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet (1988) 1.35
Folate deficiency in Crohn's disease: incidence, pathogenesis, and treatment. Br Med J (1968) 1.34
Multiparameter studies in lymphoid leukemias. Am J Clin Pathol (1979) 1.34
Folate deficiency in premature infants. Arch Dis Child (1970) 1.33
Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia. Leukemia (2009) 1.33
Iron and folate metabolism in tuberculosis. Br Med J (1966) 1.33
A new recurrent translocation t(11;14)(q24;q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia. Leukemia (2010) 1.31
Orally active alpha-ketohydroxy pyridine iron chelators intended for clinical use: in vivo studies in rabbits. Br J Haematol (1986) 1.31
Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells. Br J Haematol (1976) 1.30
High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation. Acta Haematol (1990) 1.30
Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemia. Lancet (1980) 1.29
Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow. Lancet (1986) 1.29
Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases. Leukemia (2003) 1.28
Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization. Oncogene (2007) 1.28
Streptococcus mitis and ARDS in neutropenic patients. Lancet (1991) 1.28
Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one. Br Med J (Clin Res Ed) (1987) 1.28
Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside. Br J Haematol (1974) 1.28
Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: a multicenter randomized controlled trial. J Pediatr (1986) 1.28
Splenic atrophy in dermatitis herpetiformis. Br Med J (1972) 1.25
Studies of folate uptake by phytohaemagglutinin-stimulated lymphocytes. Br J Haematol (1970) 1.25
Comparison of three methods for measuring vitamin B 12 in serum: radioisotopic, euglena gracilis and Lactobacillus leichmannii. Br J Haematol (1972) 1.23
Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics (1993) 1.22
Indices of granulocyte activity in inflammatory bowel disease. Gut (1974) 1.21
Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome. Leukemia (2004) 1.21
Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J Exp Med (1993) 1.20
Alternate-pathway complement fixation by IgA in the skin in dermatitis herpetiformis. Lancet (1973) 1.20
Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. Clin Infect Dis (1993) 1.19
Yeast heat shock transcription factor contains a flexible linker between the DNA-binding and trimerization domains. Implications for DNA binding by trimeric proteins. J Biol Chem (1994) 1.19
1,2-Dimethyl-3-hydroxypyrid-4-one, an orally active chelator for treatment of iron overload. Lancet (1987) 1.19
Solution structure of the DNA-binding domain of the heat shock transcription factor determined by multidimensional heteronuclear magnetic resonance spectroscopy. Protein Sci (1994) 1.19
Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer (2010) 1.18
Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine. J Clin Pathol (1987) 1.17
Postnatal encephaloclastic porencephaly--a new lesion? Arch Dis Child (1992) 1.17
High prevalence of low bone mass in thalassaemia major. Br J Haematol (1998) 1.15
Development of pluripotent hematopoietic progenitor cells in the human fetus. Blood (1983) 1.15
Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome. Leukemia (2003) 1.15
Effect of ascorbic acid deficiency on serum ferritin concentration in patients with beta-thalassaemia major and iron overload. J Clin Pathol (1982) 1.14
Absorption of vitamin B 12 by the guinea-pig. I. Subcellular localization of vitamin B 12 in the ileal enterocyte during absorption. Br J Haematol (1970) 1.13
Heavy metal intoxication from homeopathic and herbal remedies. Postgrad Med J (1994) 1.12
The effect of deoxyuridine, vitamin B12, folate and alcohol on the uptake of thymidine and on the deoxynucleoside triphosphate concentrations in normal and megaloblastic cells. Br J Haematol (1978) 1.12
Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A. Lancet (1981) 1.11
The effect of external deoxyribonucleosides on deoxyribonucleoside triphosphate concentrations in human lymphocytes. Biochem Pharmacol (1975) 1.10
The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients. Haematologica (2001) 1.10
A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin. Leukemia (2008) 1.08